27 Mar 2015 07:00
27 March 2015
Amiad Water Systems Ltd.
("Amiad" or "the Company")
Appointment of Non-Executive Director
Amiad (AIM: AFS), a leading global producer of water treatment and filtration solutions, is pleased to announce the appointment of Dr. Gilead Fortuna as a Non-Executive Director of the Company and a member of the Board of Directors with immediate effect.
Dr. Fortuna, aged 73, has over 40 years' experience in business development, strategy and R&D, primarily in the technology, chemical engineering - including water treatment - and pharmaceutical sectors. He holds a BSc and MSc from the Technion - Israel's Institute of Technology - and a PhD in Chemical Engineering from the University of Illinois. During his career, he has held the position of CTO at ICL-Israel Chemicals Ltd. (NYSE and TASE: ICL) ("ICL"), as well as holding President and CEO positions at subsidiaries of ICL. He has also held senior business development roles at Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA). In addition, in 2000, he established Aquise Ltd., a water treatment company in Israel. Dr. Fortuna is an experienced director and board member having served on the Board of Rotem Amfert Negev Ltd., Bromine Group Ltd. and Enzymotec Ltd. until it floated on NASDAQ in 2013.
Currently, Dr. Fortuna serves as a Senior Research Fellow, Founder and Head of the "Center for Industrial Excellence" at the Samuel Neaman Institute for National Policy Research. As part of this role, Dr. Fortuna is a consultant to Newtech, a government agency responsible for advancing Israel's national water and energy program. Dr. Fortuna is also a consultant of Elcon Recycling Center, a company that develops innovative industrial wastewater treatment solutions, and serves on the management board of the Technion and as member of the committee of Science R&D policy of the Israeli Ministry of Science. In addition, he has acted as Visiting Professor in the Faculty of Engineering at the City University of New York.
Eli Opper, Chairman of Amiad, said: "We are delighted to welcome Dr. Gilead Fortuna to the Board of Amiad. His wealth of experience in technology and engineering, including the water industry, will be of great benefit to Amiad as we continue to innovate and progress."
Other than set out below, there are no other matters required to be disclosed pursuant to paragraph (g) of Schedule Two to the AIM Rules for Companies as regards Dr. Fortuna's appointment.
Regulatory disclosures:
Dr. Gilead Fortuna | |
Current Directorships | Directorships within the last five years |
The Technion - Israel Institute of Technology (Board of Governors)
Ort Braude College (Board of Governors) | Enzymotec Ltd. |
Enquiries:
Amiad Water Systems Ltd. |
|
Arik Dayan, Chief Executive Officer Irit Ben-Dov, Chief Financial Officer | +972 4 690 9500 |
| |
Stifel Nicolaus Europe Ltd |
|
Giles Balleny | +44 20 7710 7600 |
| |
Luther Pendragon Ltd. |
|
Harry Chathli, Claire Norbury, Oliver Hibberd | +44 20 7618 9100 |
About Amiad
Amiad Water Systems (AIM: AFS) is a leading global producer of automatic, self-cleaning water treatment and filtration products and systems. Through its engineering skills and ability to innovate, Amiad provides cost-effective "green" solutions for the industrial, municipal, irrigation, oil & gas and ballast water markets. In these segments its patented products are being integrated into the core of systems for filtration and water treatment, micro irrigation and membrane protection, wastewater and potable water treatment, cooling systems and sea water filtration.
Headquartered in Israel, Amiad provides these solutions through nine subsidiaries and a comprehensive network of over 170 distributors to customers in more than 80 countries.
For additional information or product details, please visit www.amiad.com.